Idiopathic Thrombocytopenic Purpura
📧 Sign up to get email alerts when something new happens for Idiopathic Thrombocytopenic Purpura.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-12-25Clinical Trial Update: Hemostasis in Patients With Idiopathic Thrombocytopenic Purpura
A completed clinical trial (NCT01571349) from Samsung Medical Center evaluating hemostasis in patients with idiopathic thrombocytopenic purp…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: A Study in Healthy Subjects to Evaluate Bioavailability of 4 Formulations of E5501 [Phase 1]
Phase 1 study in healthy subjects evaluating the bioavailability of four formulations of E5501; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-08Clinical Trial Update: Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura [Phase 3]
Phase 3 trial comparing romiplostim to standard of care in immune (idiopathic) thrombocytopenic purpura (ITP) has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura [Phase 4]
A Phase 4 trial evaluating Helicobacter pylori infection in children with chronic idiopathic thrombocytopenic purpura has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP) [Phase 2]
A Phase 2 trial evaluating SB-497115, an oral thrombopoietin receptor agonist, versus placebo in adults with refractory immune thrombocytope…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP) [Phase 1, Phase 2]
This clinical trial evaluated rituximab in children and adolescents with chronic idiopathic thrombocytopenic purpura (ITP) and has completed…
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag [Phase 4]
Phase 4 update on platelet function in Idiopathic Thrombocytopenic Purpura patients treated with eltrombopag. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: Eltrombopag Taste Testing in Healthy Adult Volunteers [Phase 1]
Phase 1 clinical trial update on eltrombopag involving taste testing in healthy adult volunteers, sponsored by GlaxoSmithKline.
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: Subject Variability in Two Lots of E5501 Administered to Fed and Fasted Healthy Subjects [Phase 1]
Phase 1 pharmacokinetic variability study evaluating two lots of E5501 administered to fed and fasted healthy subjects.
-
CLINICAL_TRIALS trial_result · 2012-02-13Clinical Trial Update: An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP [Phase 3]
Open-label Phase 3 trial of romiplostim in adults with immune thrombocytopenia (ITP) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2011-12-01Clinical Trial Update: Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP) [Phase 3]
Phase 3 trial evaluating eltrombopag for chronic idiopathic thrombocytopenic purpura (ITP) completed with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-03-01Clinical Trial Update: Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects [Phase 1, Phase 2]
Phase 1/2 study evaluating safety and efficacy of romiplostim in pediatric idiopathic thrombocytopenic purpura completed; results posted in …
-
CLINICAL_TRIALS trial_result · 2011-01-13Clinical Trial Update: High Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITP [Phase 3]
A Phase 3 trial comparing high-dose dexamethasone with conventional-dose prednisolone in adults with idiopathic thrombocytopenic purpura has…
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: P3 Study to Evaluate Efficacy and Safety of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic Purpura [Phase 3]
Phase 3 trial evaluating AMG 531 in thrombocytopenic Japanese patients with idiopathic thrombocytopenic purpura has completed with results p…
-
CLINICAL_TRIALS trial_result · 2010-08-30Clinical Trial Update: Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias [Phase 2, Phase 3]
This clinical trial investigates combining alemtuzumab and rituximab to treat refractory autoimmune cytopenias, including idiopathic thrombo…
-
CLINICAL_TRIALS trial_result · 2010-07-16Clinical Trial Update: Effects of Long-term Dosing of AMG 531 on Bone Marrow Morphology
A completed trial evaluating the effects of long-term AMG 531 (romiplostim) dosing on bone marrow morphology in patients with idiopathic thr…
-
CLINICAL_TRIALS trial_result · 2010-05-12Clinical Trial Update: Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Amgen sponsored a retrospective and prospective observational study of patients with idiopathic thrombocytopenic purpura (ITP); the trial st…
-
CLINICAL_TRIALS trial_result · 2009-02-03Clinical Trial Update: Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D [Phase 2]
A Phase 2 trial evaluating subcutaneously administered Anti-D for idiopathic thrombocytopenic purpura has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers
A completed NHLBI observational trial in immune thrombocytopenia examined how platelet counts relate to endogenous thrombopoietin levels, en…